Capital Asset Advisory Services’s Emergent Biosolutions EBS Stock Holding History

Capital Asset Advisory Services’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-4,245	Closed	-$267K	–	713
2021 Q2	$267K	Sell	4,245 -222	-5%	-$14.3K	0.03%	379
2021 Q1	$415K	Sell	4,467 -417	-9%	-$42.7K	0.06%	286
2020 Q4	$438K	Sell	4,884 -174	-3%	-$16K	0.08%	219
2020 Q3	$523K	Sell	5,058 -219	-4%	-$23.6K	0.11%	151
2020 Q2	$646K	Sell	5,277 -682	-11%	-$50.8K	0.14%	132
2020 Q1	$484K	Sell	5,959 -254	-4%	-$14.6K	0.13%	135
2019 Q4	$390K	Sell	6,213 -416	-6%	-$22.6K	0.09%	215
2019 Q3	$347K	Buy	6,629 +320	+5%	+$14.9K	0.23%	78
2019 Q2	$305K	Buy	+6,309	New	+$302K	0.24%	82
2019 Q1	–	Sell	-8,255	Closed	-$489K	–	83
2018 Q4	$489K	Sell	8,255 -453	-5%	-$29.2K	0.47%	51
2018 Q3	$573K	Buy	8,708 +326	+4%	+$19K	0.48%	48
2018 Q2	$423K	Sell	8,382 -1,441	-15%	-$75.1K	0.38%	59
2018 Q1	$517K	Sell	9,823 -360	-4%	-$17.9K	0.48%	52
2017 Q4	$473K	Sell	10,183 -2,138	-17%	-$90K	0.43%	62
2017 Q3	$498K	Sell	12,321 -65	-0.5%	-$2.35K	0.45%	56
2017 Q2	$416K	Buy	+12,386	New	+$382K	0.27%	85

Other funds holding EBS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $128B AUM 35.83% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.79B AUM 33.56% 1-Year Est. Return

Capital Asset Advisory Services's EBS Position: Q3 2021 in Review

Capital Asset Advisory Services sold out of Emergent Biosolutions (EBS) in Q3 2021, closing a stake of 4,245 shares — an estimated $267K sold.

Capital Asset Advisory Services first reported a position in EBS in Q2 2017 and held it in 16 quarters. The position peaked at $646K in Q2 2020. 277 funds tracked by Wall St. Rank hold EBS as of Q3 2021.

Capital Asset Advisory Services reported no remaining Emergent Biosolutions position as of Q3 2021 after selling out during the quarter.
Capital Asset Advisory Services sold 4,245 Emergent Biosolutions shares in Q3 2021, an estimated $267K.
Capital Asset Advisory Services first reported a position in Emergent Biosolutions in Q2 2017 and held it in 16 quarters.
Capital Asset Advisory Services's Emergent Biosolutions position peaked at $646K in Q2 2020.
277 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q3 2021.

Based on Capital Asset Advisory Services's 13F filing for Q3 2021, filed 14 Oct 2021.